J Cadranel
Overview
Explore the profile of J Cadranel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
3056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Millet F, Wislez M, Fallet V, Antoine M, Assouad J, Baud M, et al.
Rev Mal Respir
. 2021 Nov;
38(9):904-913.
PMID: 34756758
Introduction: The introduction of coordinated care pathways for lung cancer diagnosis and treatment is a complex process. The purpose of the French Cancer Plan 2014-2019 was to improve referral to...
12.
Rolland-Debord C, Canellas A, Choinier P, Milon A, Debrix I, Blin E, et al.
Respir Med Res
. 2021 May;
79:100828.
PMID: 34023794
Objectives: In March 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic. In absence of official recommendations, implementing daily multidisciplinary team (MDT) COVID-19 meetings was urgently...
13.
Blons H, Oudart J, Merlio J, Debieuvre D, de Fraipont F, Audigier-Valette C, et al.
Lung Cancer
. 2020 Nov;
151:69-75.
PMID: 33248711
Objectives: Tumor mutation screening is standard of care for patients with stage IV NSCLC. Since a couple of years, widespread NGS approaches used in routine diagnostics to detect driver mutations...
14.
Ruppert A, Amrioui F, Giol M, Assouad J, Cadranel J, Gounant V
Respir Med Res
. 2020 Nov;
78:100793.
PMID: 33142192
No abstract available.
15.
Laskin J, Liu S, Tolba K, Heining C, Schlenk R, Cheema P, et al.
Ann Oncol
. 2020 Sep;
31(12):1693-1703.
PMID: 32916265
Oncogenic gene fusions are hybrid genes that result from structural DNA rearrangements, leading to deregulated activity. Fusions involving the neuregulin-1 gene (NRG1) result in ErbB-mediated pathway activation and therefore present...
16.
Bejan-Angoulvant T, Naccache J, Caille A, Borie R, Nunes H, Ferreira M, et al.
Respir Med Res
. 2020 Aug;
78:100770.
PMID: 32777737
Introduction: Nonspecific interstitial pneumonia (NSIP) are rare but severe diseases, with high mortality and morbidity, with no effective pharmacological treatment allowing for long-term remission, and therefore no clear therapeutic recommendations....
17.
Girard N, Greillier L, Zalcman G, Cadranel J, Moro-Sibilot D, Mazieres J, et al.
Respir Med Res
. 2020 Jun;
78:100769.
PMID: 32563968
The objective of this document is to formalize a degraded mode management for patients with thoracic cancers in the context of the COVID-19 pandemic. The proposals are based on those...
18.
Fontaine-Delaruelle C, Mazieres J, Cadranel J, Mastroianni B, Dubos-Arvis C, Dumont P, et al.
Respir Med Res
. 2020 May;
77:58-66.
PMID: 32416585
Background: Lung cancer in women is on the rise, with a higher proportion occurring in lifelong never-smokers. Lung cancer in never-smokers (LCINS) exhibits a high frequency of driver oncogene alterations....
19.
Ruppert A, Lavole A, Makinson A, Le Maitre B, Cadranel J
Rev Mal Respir
. 2020 Mar;
37(3):267-274.
PMID: 32197931
Lung cancer is the leading cause of cancer related death among people living with HIV (PLHIV). Tobacco exposure is higher among PLHIV (38.5%) and mainly explains the increased risk of...
20.
Mazieres J, Cropet C, Montane L, Barlesi F, Souquet P, Quantin X, et al.
Ann Oncol
. 2020 Jan;
31(2):289-294.
PMID: 31959346
Background: BRAF mutations occurring in 1%-5% of patients with non-small-cell lung cancer (NSCLC) are therapeutic targets for these cancers but the impact of the exact mutation on clinical activity is...